Pathobiodynamics: reduction in hepatic and intestinal ligandin (glutathione-S-transferase) levels in rats with severe acute and chronic inflammation.
D000818:Animals; D001168:Arthritis / Q000201:enzymology*; D001169:Arthritis, Experimental / Q000188:drug therapy / Q000201:enzymology*; D003300:Copper / Q000494:pharmacology; D003600:Cytosol / Q000378:metabolism; D005982:Glutathione Transferase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D007213:Indomethacin / Q000494:pharmacology; D007421:Intestine, Small / Q000201:enzymology*; D008099:Liver / Q000201:enzymology* / Q000378:metabolism; D008297:Male; D010634:Phenobarbital / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D051381:Rats; D013438:Sulfhydryl Compounds / Q000378:metabolism; D013448:Sulfobromophthalein / Q000378:metabolism
D013438:Sulfhydryl Compounds; D013448:Sulfobromophthalein; D003300:Copper; D005982:Glutathione Transferase; D010653:Phenylbutazone; D007213:Indomethacin; D010634:Phenobarbital